Cellectis S.A. - American Depositary Shares (CLLS)
1.1800
-0.1500 (-11.28%)
NASDAQ · Last Trade: Nov 15th, 4:46 PM EST
What Cellectis (CLLS) Said on Its Q3 Earnings Callmarketbeat.com
Cellectis (NASDAQ:CLLS) said its cash runway is expected to extend into the second half of 2028 once its planned restructuring is fully implemented, giving the gene editing company time to reach anticipated initial clinical readouts for its two lead programs.
The company expects preliminary data fr
Via MarketBeat · November 13, 2026
Oct. 28 Gap Stocks: Double-Digit Gap-Up and Gap-Down Moverschartmill.com
Via Chartmill · October 28, 2026
Cellectis Unveils In Vivo Gene-Editing Plans for Severe Lipid Disordersmarketbeat.com
Cellectis (NASDAQ:CLLS) outlined plans to advance two preclinical in vivo gene-editing candidates for severe forms of dyslipidemia, targeting hypertriglyceridemia and hypercholesterolemia through one-time intravenous treatments.
Chief Executive Officer André Choulika said the company is building on
Via MarketBeat · October 1, 2026
Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipelinefool.com
Bright Minds Biosciences develops serotonin-based therapeutics for neurological and neuropsychiatric conditions in a pre-clinical model.
Via The Motley Fool · May 21, 2026
Why This Fund Added $12 Million to a Biotech Stock That's Now Down 58% in a Yearfool.com
ADMA Biologics develops plasma-derived therapies for immune deficiencies and infectious diseases, leveraging a vertically integrated model.
Via The Motley Fool · May 21, 2026
Structure Therapeutics Slides 28% This Year as $6 Million Stake Emergesfool.com
Structure Therapeutics advances oral therapies for diabetes, obesity, and pulmonary disease through its clinical-stage drug pipeline.
Via The Motley Fool · March 22, 2026
Traders are paying attention to the gapping stocks in Monday's session.chartmill.com
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday.
Via Chartmill · December 29, 2025
Why Cellectis Stock Is Trading Higher Todaybenzinga.com
Cellectis reports strong Nature Communications data showing CssDNA boosts non-viral gene insertion efficiency and supports long-term therapeutic potential.
Via Benzinga · November 19, 2025
European ADRs Navigate Choppy Waters: Pharma Sector Shows Resilience Amidst Broader Market Volatility
European American Depositary Receipts (ADRs) have recently experienced a period of significant fluctuation, reflecting a broader climate of market volatility that has ripple across global financial markets. While the general trend has seen some recent slips, the pharmaceutical sector, a traditionally defensive industry, has demonstrated a mixed performance, showcasing both
Via MarketMinute · November 19, 2025
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 20, 2025
Thursday's session: gap up and gap down stockschartmill.com
Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.
Via Chartmill · October 16, 2025
Enerpac Tool Group Posts Upbeat Results, Joins Praxis Precision Medicines, J B Hunt, Salesforce And Other Big Stocks Moving Higher On Thursdaybenzinga.com
Via Benzinga · October 16, 2025
Top 2 Health Care Stocks That May Keep You Up At Night This Monthbenzinga.com
Via Benzinga · October 16, 2025
Stay updated with the stocks that are on the move in today's pre-market session.chartmill.com
The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · October 16, 2025
Wondering what's happening in today's pre-market session?chartmill.com
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via Chartmill · September 29, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The market value of their outstanding shares is at $10.5 million.
Via Benzinga · September 29, 2025
Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Sessionbenzinga.com
U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Monday. Shares of Inventiva ADR (NASDAQ: IVA) fell sharply in today's pre-market trading following H1 results.
Via Benzinga · September 29, 2025
Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarketbenzinga.com
Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announced plans to acquire Merus for $8 billion in all-cash deal adding breakthrough therapy Petosemtamab to its late-stage pipeline.
Via Benzinga · September 29, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · September 19, 2025
Top 5 Biotech Stocks With Strong Momentumbenzinga.com
Top 5 biotech stocks jumping into the top 10% momentum this week—ADCT, ARQT, CLLS, ENTO, HOTH—amid rapid sector rallies.
Via Benzinga · August 28, 2025

